The pregnancy hormone relaxin binds to and activates the human glucocorticoid receptor

Annals of the New York Academy of Sciences

Volumn 1041, Issue , 2005, Pages 256-271

  Dschietzig, Thomas ^a   Bartsch, Cornelia ^a   Greinwald, Michael ^a   Baumann, Gert ^a   Stangl, Karl ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cytokines; Glucocorticoids; Macrophages; Receptor; Signal transduction

Indexed keywords

CYTOKINE; DNA; ENDOTOXIN; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 6; LUCIFERASE; RELAXIN; TUMOR NECROSIS FACTOR ALPHA;

CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA BINDING; FEMALE; FIBROBLAST; HELA CELL; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; MACROPHAGE; PREGNANCY; SIGNAL TRANSDUCTION; SPLEEN CELL;

EID: 23644461401     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1282.039     Document Type: Conference Paper

References (28)

1. GOLDSMITH, L.T., G. WEISS & B.C. STEINETZ. 1995. Relaxin and its role in pregnancy. Endocrinol. Metab. Clin. North Am. 24: 171-186.
2. DSCHIETZIG, T. & K. STANGL. 2003. Relaxin: a pregnancy hormone as central player of body fluid and circulation homeostasis. Cell. Mol. Life Sci. 60: 688-700.
3. BANI, D. 1997. Relaxin: a pleiotropic hormone. Gen. Pharmacol. 28: 13-22.
4. DSCHIETZIG, T., C. RICHTER, C. BARTSCH, et al. 2001. The pregnancy hormone relaxin is a player in human heart failure. FASEB J. 15: 2187-2195.
5. HSU, S.Y., K. NAKABAYASHI, S. NISHI, et al. 2002. Activation of orphan receptors by the hormone relaxin. Science 295: 671-674.
6. KUMAGAI, J., S. Y. HSU, H. MATSUMI, et al. 2002. INSL3/litereydig insulin-like peptide activates the LGR8 receptor important in testis descent. J. Biol. Chem. 277: 31283-31286.
7. SUNDER, S. & E.A. LENTON. 2000. Endocrinology of the peri-implantation period. Baillieres Best Pract. Res. Clin. Obstet. Gynaecol. 14: 789-800.
8. BANI, D., L. BALLATI, E. MASINI, et al. 1997. Relaxin counteracts asthma-like reaction induced by inhaled antigen in sensitized guinea pigs. Endocrinology 138: 1909-1915.
9. PICCINNI, M.P., D. BANI, L. BELONI, et al. 1999. Relaxin favors the development of activated human T cells into Th1-like effectors. Eur. J. Immunol. 29: 2241-2247.
10. BAMBERGER, C.M., H.M. SCHULTE & G.P. CHROUSOS. 1996. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr. Rev. 17: 245-261.
11. BARNES, P.J. 1998. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin. Sci. 94: 557-572.
12. RAJAPANDI, T., L.E. GREENE & E. EISENBERG. 2000. The molecular chaperones Hsp90 and Hsc70 are both necessary and sufficient to activate hormone binding by glucocorticoid receptor. J. Biol. Chem. 275: 22597-22604.
13. PUJOLS, L., J. MULLOL, J. ROCA-FERRER, et al. 2002. Expression of glucocorticoid receptor alpha- and beta-isoforms in human cells and tissues. Am. J. Physiol. Cell Physiol. 283: C1324-C1331.
14. OAKLEY, R.H., C.M. JEWELL, M.R. YUDT, et al. 1999. The dominant negative activity of the human glucocorticoid receptor beta isoform. Specificity and mechanisms of action. J. Biol. Chem. 274: 27857-27866.
15. LARUE, K.E. & C.E. MCCALL. 1994. A labile transcriptional repressor modulates endotoxin tolerance. J. Exp. Med. 180: 2269-2275.
16. HABER, P.L., T.G. OSBORN & T.L. MOORE. 1989. Antinuclear antibody in juvenile rheumatoid arthritis sera reacts with 50-40 kDa antigen(s) found in HeLa nuclear extracts. J. Rheumatol. 16: 949-954.
17. BORTZ, J., G.A. LIENERT & K. BOEHNKE. 1990. Verteilungsfreie Methoden in der Biostatistik. Springer Verlag. Berlin. [In German.]
18. HOLM, S. 1979. A simple sequentially rejective multiple test procedure. Scand. J. Stat. 6: 65-70.
19. BOURGEOIS, S., M. PFAHL & E.E. BAULIEU. 1984. DNA binding properties of glucocorticosteroid receptors bound to the steroid antagonist RU-486. EMBO J. 3: 751-755.
20. DSCHIETZIG, T., C. BARTSCH, C. RICHTER, et al. 2003. Relaxin, a pregnancy hormone, is a functional endothelin-1 antagonist: attenuation of endothelin-1-mediated vasoconstriction by stimulation of endothelin type-B receptor expression via ERK-1/2 and nuclear factor-kappaB. Circ. Res. 92: 32-40.
21. ALMAWI, W.Y & O.K. MELEMEDJIAN. 2002. Molecular mechanisms of glucocorticoid antiproliferative effects: antagonism of transcription factor activity by glucocorticoid receptor. J. Leuk. Biol. 71: 9-15.
22. BUELLESBACH, E.E. & C. SCHWABE. 2001. The relaxin receptor-binding site geometry suggests a novel gripping mode of interaction. J. Biol. Chem. 275: 35276-35280.
23. BLEDSOE, R.K., V.G. MONTANA, T.B. STANLEY, et al. 2002. Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell 110: 93-105.
24. MASINI, E., G. ZAGLI, J.F. NDISANG, et al. 2002. Protective effect of relaxin in cardiac anaphylaxis: involvement of the nitric oxide pathway. Br. J. Pharmacol. 137: 337-344.
25. DAYANITHI, G., M. CAZALIS & J.J. NORDMANN. 1987. Relaxin affects the release of oxytocin and vasopressin from the neurohypophysis. Nature 325: 813-816.
26. NEUMANN, I.D. 2002. Involvement of the brain oxytocin system in stress coping: interactions with the hypothalamo-pituitary-adrenal axis. Prog. Brain Res. 139: 147-162.
27. WATTERS, J.J., P. POULIN & D.M. DORSA. 1998. Steroid hormone regulation of vasopressinergic neurotransmission in the central nervous system. Prog. Brain Res. 119: 247-261.
28. SEIBOLD, J.R., J.H. KORN, R. SIMMS, et al. 2000. Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 132: 871-879.